Rong Yan, MS

/
Zhongda Hospital Affiliated to Southeast University, China (People's Republic)

Presentation(s):

• Is TACE with Atezolizumab-Bevacizumab the Next Step Forward in HCC? Longer Survival Linked to Sequential Systemic Therapy First

  Tuesday, April 1, 2025
  3:45 PM – 3:54 PM CT